BSE Live
Oct 29, 09:52Prev. Close
683.85
Open Price
687.00
Bid Price (Qty.)
681.00 (1)
Offer Price (Qty.)
682.75 (7)
NSE Live
Oct 29, 09:52Prev. Close
683.80
Open Price
683.80
Bid Price (Qty.)
680.70 (6)
Offer Price (Qty.)
681.95 (1)
| Key Financial Ratios of Astec Lifesciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -68.74 | -23.96 | 13.02 | 45.85 | 33.05 | |
| Diluted EPS (Rs.) | -68.74 | -23.96 | 13.02 | 45.83 | 33.02 | |
| Cash EPS (Rs.) | -46.42 | -5.44 | 30.21 | 63.39 | 46.16 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 119.36 | 188.01 | 213.61 | 202.06 | 157.60 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 119.36 | 188.01 | 213.61 | 202.06 | 157.60 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 1.50 | 1.50 | 1.50 | |
| Revenue from Operations/Share (Rs.) | 194.43 | 233.66 | 320.40 | 345.23 | 283.28 | |
| PBDIT/Share (Rs.) | -30.92 | -0.16 | 45.55 | 83.96 | 60.84 | |
| PBIT/Share (Rs.) | -53.24 | -18.68 | 28.35 | 66.40 | 47.71 | |
| PBT/Share (Rs.) | -71.96 | -31.55 | 17.77 | 61.76 | 45.27 | |
| Net Profit/Share (Rs.) | -68.74 | -23.96 | 13.02 | 45.83 | 33.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -15.90 | -0.06 | 14.21 | 24.32 | 21.47 | |
| PBIT Margin (%) | -27.38 | -7.99 | 8.84 | 19.23 | 16.84 | |
| PBT Margin (%) | -37.00 | -13.50 | 5.54 | 17.89 | 15.98 | |
| Net Profit Margin (%) | -35.35 | -10.25 | 4.06 | 13.27 | 11.65 | |
| Return on Networth / Equity (%) | -57.59 | -12.74 | 6.09 | 22.68 | 20.95 | |
| Return on Capital Employed (%) | -20.28 | -6.34 | 12.28 | 32.07 | 26.33 | |
| Return on Assets (%) | -15.31 | -4.82 | 2.60 | 10.01 | 9.54 | |
| Total Debt/Equity (X) | 2.37 | 1.34 | 0.81 | 0.71 | 0.61 | |
| Asset Turnover Ratio (%) | 0.41 | 0.47 | 0.67 | 0.86 | 81.85 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.93 | 1.00 | 0.95 | 1.05 | 1.02 | |
| Quick Ratio (X) | 0.49 | 0.51 | 0.39 | 0.67 | 0.69 | |
| Inventory Turnover Ratio (X) | 2.13 | 1.30 | 1.91 | 3.04 | 5.23 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | -6.25 | 11.52 | 3.27 | 4.53 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | -27.55 | 4.96 | 2.36 | 3.24 | |
| Earnings Retention Ratio (%) | 0.00 | 106.25 | 88.48 | 96.73 | 95.47 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 127.55 | 95.04 | 97.64 | 96.76 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,876.42 | 2,575.09 | 3,050.19 | 3,711.94 | 2,144.81 | |
| EV/Net Operating Revenue (X) | 4.92 | 5.62 | 4.86 | 5.49 | 3.87 | |
| EV/EBITDA (X) | -30.95 | -8,069.87 | 34.16 | 22.56 | 18.00 | |
| MarketCap/Net Operating Revenue (X) | 3.47 | 4.55 | 4.31 | 5.08 | 3.53 | |
| Retention Ratios (%) | 0.00 | 106.25 | 88.47 | 96.72 | 95.46 | |
| Price/BV (X) | 5.65 | 5.65 | 6.47 | 8.67 | 6.35 | |
| Price/Net Operating Revenue | 3.47 | 4.55 | 4.31 | 5.08 | 3.53 | |
| Earnings Yield | -0.10 | -0.02 | 0.01 | 0.03 | 0.03 |
29.07.2025
Astec Life Consolidated June 2025 Net Sales at Rs 91.08 crore, up 31.29% Y-o-Y
29.07.2025
Astec Life Standalone June 2025 Net Sales at Rs 91.08 crore, up 31.29% Y-o-Y
24.04.2025
Astec Life Consolidated March 2025 Net Sales at Rs 119.53 crore, down 22.26% Y-o-Y
24.04.2025
Astec Life Standalone March 2025 Net Sales at Rs 119.53 crore, down 22.26% Y-o-Y